The renin-angiotensin-aldosterone axis exerts major control over sodium and potassium balance and arterial blood pressure. These three functions are continuously regulated by changes in angiotensin II and aldosterone levels in response to wide variations in dietary intake of sodium and potassium. In addition, changes in intrarenal physical factors cause changes in the supply of distal tubular sodium that, in turn, work to determine sodium and potassium excretion and to modulate the release of renal renin. However, certain aspects of sodium homeostasis cannot be fully explained either by the activity of the renin system or by intrarenal physical factors, and this has led investigators to search for other natriuretic hormonal mechanisms. Recently, it has become clear that atrial tissue contains a group of peptides, at least one of which is probably secreted as a regulatory hormone. In animals, these atrial peptides produce immediate, marked natriuresis associated with a rise in glomerular filtration rate (but no alteration of total renal flow) and a simultaneous decrease in arterial blood pressure. Atrial peptides also inhibit renal renin secretion and adrenal cortical secretion of aldosterone, and they oppose the vasoconstrictive action of angiotensin II. One of these atrial peptides may therefore be the long-sought natriuretic hormone, though in a different form and shape than was envisioned. The fact that atrial peptide works to oppose the renin system at four points suggests that this new hormone could have a major complementary role in long-term regulation of blood pressure and electrolyte homeostasis. In this construction the renin system primarily defends sodium balance and blood pressure, with the atrial hormone having an increasing counter-influence in situations involving high blood pressure or sodium surfeit. We can soon expect to learn more about this atrial hormone, including which peptide is the active circulating hormone, what induces or inhibits its release, and what part it plays in cardiovascular diseases.
This article has been cited by other articles:
Manunta, P., Hamilton, B. P., Hamlyn, J. M.
(2006). Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am. J. Physiol. Regul. Integr. Comp. Physiol.
290: R553-R559
[Abstract][Full Text]
Suzuki, S., Yoshimura, M., Nakayama, M., Mizuno, Y., Harada, E., Ito, T., Nakamura, S., Abe, K., Yamamuro, M., Sakamoto, T., Saito, Y., Nakao, K., Yasue, H., Ogawa, H.
(2004). Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial Infarction: A Long-Term Follow-Up Analysis. Circulation
110: 1387-1391
[Abstract][Full Text]
Brancaccio, G., Michielon, G., Di Donato, R. M, Costa, D., Falzea, F., Miraldi, F.
(2004). Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass. Perfusion
19: 157-162
[Abstract]
Moazami, N., Damiano, R. J., Bailey, M. S., Hess, R. L., Lawton, J. S., Moon, M. R., Pasque, M. K.
(2003). Nesiritide (BNP) in the management of postoperative cardiac patients. Ann. Thorac. Surg.
75: 1974-1976
[Abstract][Full Text]
Marenzi, G., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Famoso, G., Agostoni, P.
(2002). Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure. Eur J Heart Fail
4: 597-603
[Abstract][Full Text]
Zullo, M. A.
(2002). Characteristics of the Acute Rise of Atrial Natriuretic Factor During Ventricular Pacing*. Chest
121: 1942-1946
[Abstract][Full Text]
Nakamura, T., Sakamoto, K., Yamano, T., Kikkawa, M., Zen, K., Hikosaka, T., Kubota, T., Azuma, A., Nishimura, T.
(2002). Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol
39: 1657-1663
[Abstract][Full Text]
Suzuki, T., Yamazaki, T., Yazaki, Y.
(2001). The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res
51: 489-494
[Abstract][Full Text]
Ootaki, Y., Okada, M., Tsukube, T., Okita, Y.
(2001). The Effect of Cardiomyoplasty on Left Atrial Function in Experimental Canine Models. Chest
119: 1526-1532
[Abstract][Full Text]
Hayashida, N., Chihara, S., Kashikie, H., Tayama, E., Yokose, S., Akasu, K., Aoyagi, S.
(2000). Effects of intraoperative administration of atrial natriuretic peptide. Ann. Thorac. Surg.
70: 1319-1326
[Abstract][Full Text]
Nakayama, T., Soma, M., Takahashi, Y., Rehemudula, D., Kanmatsuse, K., Furuya, K.
(2000). Functional Deletion Mutation of the 5'-Flanking Region of Type A Human Natriuretic Peptide Receptor Gene and Its Association With Essential Hypertension and Left Ventricular Hypertrophy in the Japanese. Circ. Res.
86: 841-845
[Abstract][Full Text]
Horio, T., Nishikimi, T., Yoshihara, F., Matsuo, H., Takishita, S., Kangawa, K.
(2000). Inhibitory Regulation of Hypertrophy by Endogenous Atrial Natriuretic Peptide in Cultured Cardiac Myocytes. Hypertension
35: 19-24
[Abstract][Full Text]
Valsson, F., Lundin, S., Kirno, K., Hedner, T., Houltz, E., Saito, Y., Ricksten, S.-E.
(1999). Atrial Natriuretic Peptide Attenuates Pacing-Induced Myocardial Ischemia During General Anesthesia in Patients with Coronary Artery Disease. Anesth. Analg.
88: 279-279
[Abstract][Full Text]
Fujishige, K., Yanaka, N., Akatsuka, H., Omori, K.
(1998). Localization of clearance receptor in rat lung and trachea: association with chondrogenic differentiation. Am. J. Physiol. Lung Cell. Mol. Physiol.
274: L425-L431
[Abstract][Full Text]
Clarkson, P. B.M., Wheeldon, N. M., MacFadyen, R. J., Pringle, S. D., MacDonald, T. M.
(1996). Effects of Brain Natriuretic Peptide on Exercise Hemodynamics and Neurohormones in Isolated Diastolic Heart Failure. Circulation
93: 2037-2042
[Abstract][Full Text]
Schreij, G., van Es, P. N., Schiffers, P. M.H., de Leeuw, P. W.
(1996). Renal Extraction of Atrial Natriuretic Peptide in Hypertensive Patients With or Without Renal Artery Stenosis. Hypertension
27: 1254-1258
[Abstract][Full Text]
Lin, K.-F., Chao, J., Chao, L.
(1995). Human Atrial Natriuretic Peptide Gene Delivery Reduces Blood Pressure in Hypertensive Rats. Hypertension
26: 847-853
[Abstract][Full Text]
Sala, C., Campise, M., Ambroso, G., Motta, T., Zanchetti, A., Morganti, A.
(1995). Atrial Natriuretic Peptide and Hemodynamic Changes During Normal Human Pregnancy. Hypertension
25: 631-636
[Abstract][Full Text]
Ganong, C. A., Kappy, M. S.
(1993). Cerebral Salt Wasting in Children: The Need for Recognition and Treatment. Arch Pediatr Adolesc Med
147: 167-169
[Abstract]
Crum, R. L., Dominic, W., Hansbrough, J. F., Shackford, S. R., Brown, M. R.
(1990). Cardiovascular and Neurohumoral Responses Following Burn Injury. Arch Surg
125: 1065-1069
[Abstract]
Cosby, R. L., Sophocles, A. M., Durr, J. A., Perrinjaquet, C. L., Yee, B., Schrier, R. W.
(1988). Elevated Plasma Atrial Natriuretic Factor and Vasopressin in High-Altitude Pulmonary Edema. ANN INTERN MED
109: 796-799
[Abstract]
Field, L.
(1988). Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science
239: 1029-1033
[Abstract]
Flier, J., Cook, K., Usher, P, Spiegelman, B.
(1987). Severely impaired adipsin expression in genetic and acquired obesity. Science
237: 405-408
[Abstract]
Anderson, J. V., Bloom, S. R., Somers, V. K., Conway, J., Sleight, P.
(1986). Hyponatremia and Ultramarathons. JAMA
256: 213-214
[Abstract]
Dillingham, M., Anderson, R.
(1986). Inhibition of vasopressin action by atrial natriuretic factor. Science
231: 1572-1573
[Abstract]
Previous
